Health & Nutrition
Drugmakers bet billions that targeted radiation could become...
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested...
Is Creatine Safe and Efficient for High Homocysteine?
Those on a healthy plant-based diet who have elevated homocysteine levels despite...
Pfizer says its experimental drug for deadly condition...
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever...
Eli Lilly says it will invest $1.8 billion to expand manufacturing...
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last...
Gilead says its twice-yearly shot cut HIV infections by...
The data sets the stage for likely approval of Gilead's lenacapavir for HIV prevention.
Digital health company Noom to offer compounded GLP-1 drug...
Digital health company Noom is offering compounded GLP-1 drugs to patients in new...
Apple turning AirPods into hearing aids underscores effort...
Apple is using its newest AirPods Pro as a way to help break into the health industry,...
Eli Lilly to invest $1.8 billion to expand manufacturing...
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last...
Moderna shares plunge on plans to cut $1.1 billion in costs,...
Moderna is deprioritizing certain parts of its pipeline, which involves pausing...
Gilead's twice-yearly shot cut HIV infections by 96% in...
The data sets the stage for likely approval of Gilead's Lenacapavir for HIV prevention.
Creatinine to Normalize Homocysteine in Vegetarians?
What are the consequences of having to make your creatine rather than relying on...
Healthy Returns: More than 50 million privately insured...
A large swath of insured Americans could be eligible for a popular class of weight...
AstraZeneca shares fall 5% on disappointing lung cancer...
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in...
Testing for Vitamin B12 Deficiency
Many doctors mistakenly rely on serum B12 levels in the blood to test for vitamin...
Alzheimer's drug Leqembi promises to give patients more...
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties,...
Healthy Returns: Eli Lilly could soon become the first...
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile,...
/cdn.vox-cdn.com/uploads/chorus_asset/file/23630242/acastro_STK052_02.jpg)
/cdn.vox-cdn.com/uploads/chorus_asset/file/25301215/STK463_SCOTUS_B.jpg)
